Clinical Trial Update: Adjuvant Versus Neoadjuvant Plus Adjuvant Chemotherapy in Resectable Pancreatic Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating adjuvant versus neoadjuvant plus adjuvant chemotherapy in resectable pancreatic cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: University of Zurich | Conditions: Pancreatic Cancer | Phase 3 | Status: TERMINATED